Skip to main content

Table 1 Baseline characteristics

From: Antipsychotic adherence patterns and health care utilization and costs among patients discharged after a schizophrenia-related hospitalization

Characteristic

All patients

Total Sample

2,541

100.00

Gender, n (%)

  

  Male

1,440

56.67

  Female

1,101

43.33

Age at Index Admission Datea

  

  Mean (SD) yrs.

41.17

12.18

  Age distribution (years), n (%)

  

   18-24

315

12.40

   25-34

493

19.40

   35-44

578

22.75

   45-54

763

30.03

   55-64

392

15.43

Race/Ethnicity, n (%)

  

  White

807

31.76

  Black

1,509

59.39

  Hispanic

16

0.63

  Other

209

8.23

Health Coverage, n (%)

  

  Fee-for-service

1,557

61.28

  Capitated

984

38.72

Basis of Medicaid Eligibility, n (%)

  

  Blind/disabled individual

2,393

94.18

  Adult (not based on unemployed status)

69

2.72

  Child (not child of unemployed adult, not foster care child)

65

2.56

  Otherb

14

0.55

Hospital Discharge Status, n (%)

  

  Discharged to home self-care

2,254

88.71

  Transfer to skilled nursing facility

47

1.85

  Transfer to other facility

122

4.80

  Left against medical advice

14

0.55

  Other alive status

1

0.04

  Not yet discharged/transferred

26

1.02

  Missing/unknown

77

3.03

Preindex Periodc All-Cause Health Care Costs

  

  Mean (SD)

$8,162.64

$10,793.97

Preindex Period Depot Antipsychotic Used, n (%)

  

Yes

126

4.96

No

2,415

95.04

Preindex Period Charlson Comorbidity Index Score

  

  Mean (SD)

0.87

1.56

  1. SD standard deviation.
  2. aThe date for the first observed schizophrenia-related inpatient admission defined the index admission date.
  3. bOther included foster-care child, aged individual, and eligibility status unknown.
  4. cThe 6-month period prior to the index admission date defined the preindex period.
  5. dDefined as at least 1 claim for depot antipsychotic preparation, including risperidone, fluphenazine, and haloperidol.